Satthea Khay, DO
Family Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Khay’s office at (408) 901-8118 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington DO.OP.61418634Osteopathic Physician & Surgeon License · since 2023 · expires 2025-10-04ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$13,695 in 2024
Medicaid paid $13,695 for 379 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 176 | $7,189 |
| Return visit (30+ min) | 82 | $4,799 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 90 | $1,165 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 14 | $331 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 17 | $210 |
| 2024 | 379 | 5 | 34 | $13,695 |
| 2023 | 25 | 1 | 24 | $891 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 25 | $891 |
Drugs they prescribed that Part D paid
$38,001
Pharmacies billed $38,001 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
263 generic and fewer than 11 brand-name prescriptions · $38,001 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $8,687 | $668 |
| Buprenorphine-Naloxone | 15 | $2,846 | $190 |
| Albuterol Sulfate Hfa | 18 | $492 | $27 |
| Gabapentin | 17 | $367 | $22 |
| Lisinopril | 19 | $291 | $15 |
See all 8 drugs
| Eliquis | 13 | $8,687 | $668 |
| Buprenorphine-Naloxone | 15 | $2,846 | $190 |
| Albuterol Sulfate Hfa | 18 | $492 | $27 |
| Gabapentin | 17 | $367 | $22 |
| Lisinopril | 19 | $291 | $15 |
| Atorvastatin | 11 | $272 | $25 |
| Metformin Hcl Er | 18 | $194 | $11 |
| Amlodipine Besylate | 11 | $124 | $11 |
Year by year
| 2024 | 323 | 60 | None | None | $38,001 |
| 2023 | 217 | 33 | 0% (0) | None | $27,800 |
| 2022 | 280 | 30 | 0% (0) | 21% | $32,604 |
| 2021 | 153 | 31 | 0% (0) | None | $13,650 |
| 2020 | 20 | None | 0% (0) | None | $2,618 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 18 | $474 | $26 |
| Albuterol Sulfate Hfa | 11 | $380 | $35 |
| Levothyroxine | 12 | $147 | $12 |
2022: 7 drugs
| Flovent Hfa | 12 | $2,617 | $218 |
| Albuterol Sulfate Hfa | 13 | $706 | $54 |
| Atorvastatin | 13 | $364 | $28 |
| Ketoconazole | 11 | $314 | $29 |
| Lisinopril | 14 | $184 | $13 |
| Topiramate | 14 | $145 | $10 |
| Amlodipine Besylate | 11 | $141 | $13 |
2021: 1 drug
| Atorvastatin | 14 | $290 | $21 |
Money from drug and device companies
$524 in 2025
A payment is not proof that care is biased.
| Agios Pharmaceuticals | Pyrukynd | $136 | 1 payment
|
| Lilly USA | Jardiance | $125 | 1 payment
|
| Merck Sharp & Dohme | Capvaxive | $124 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $116 | 1 payment
|
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
See all 6 published payments
| Agios Pharmaceuticals | Meals · 2025-10-30 | Pyrukynd | $136 |
| Merck Sharp & Dohme | Meals · 2025-09-24 | Capvaxive | $95 |
| Merck Sharp & Dohme | Meals · 2025-07-15 | M-M-R II | $29 |
| GlaxoSmithKline | Meals · 2025-06-24 | Arexvy | $23 |
| Lilly USA | Meals · 2025-04-10 | Jardiance | $125 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-27 | None | $116 |
Professional record
- NPI
- 1477058980
- Licence
- WA OP61418634Washington DO.OP.61418634: Expired
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 4400 N 1st St Bldg 7, San Jose, CA, 95134
- NPI first listed
- 2018-03-27
- NPI last updated
- 2026-09-08
- NPI record certified
- 2026-09-08
This is when the NPI record was last certified, not a medical board exam.